Frequency of Intradialytic Hypotension in Hemodialysis Patients and Its Relationship with Serum Osmolarity and Electrolytes
Intradialytic Hypotension in Hemodialysis
DOI:
https://doi.org/10.5281/zenodo.15566359Keywords:
Hemodialysis, Hypotension + Renal Dialysis, Osmolar Concentration, ElectrolytesAbstract
Objective: Intradialytic hypotension (IDH) is the most common complication of hemodialysis (HD). Many factors (cardiac factors, lack of vasoconstriction, etc.) that cause IDH have been reported so far. However, studies investigating the relationship between IDH and serum osmolarity and serum electrolytes (especially magnesium) are not sufficient. In this study, we aimed to determine the incidence of IDH in hemodialysis patients and to investigate the relationship between serum osmolarity and electrolytes and IDH.
Methods: A total of 94 patients received routine dialysis treatment at our center. Among these, 66 patients who met the inclusion criteria were included in the study. Serum osmolarity, electrolytes (sodium, potassium, calcium, magnesium), glucose and urea levels were measured from three samples drawn at the start, middle (2 hours in), and end of each session. Blood pressure was recorded every 15 minutes during HD with an ambulatory blood pressure device.
Results: IDH was detected in 29 patients (44%). In patients with IDH, blood pressure and blood glucose levels at the beginning, middle, and end of sessions were higher than those without IDH. Magnesium levels were also higher in patients with IDH in samples obtained at the end of the sessions. Independent risk factors for IDH are stated as initial glucose level, magnesium level at the end of the session, and antihypertensive drug use.
Discussion: It is important to control hypertension in patients with IDH and to prevent eating during HD sessions. Prospective studies on serum magnesium levels in the prevention of IDH are needed.
References
Chang TI. Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors. Semin Dial. 2017;30(6):532-536. doi:10.1111/sdi.12633
Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int. 2004;66(3):1212-1220. doi:10.1111/j.1523-1755.2004.00812.x
Flythe JE, Xue H, Lynch KE, Curhan GC, Brunelli SM. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol. 2015;26(3):724-734. doi:10.1681/ASN.2014020222
Van Buren PN, Inrig JK. Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension. Semin Dial. 2017;30(6):545-552. doi:10.1111/sdi.12631
Mc Causland FR, Waikar SS. Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline. Am J Kidney Dis. 2015;66(3):499-506. doi:10.1053/j.ajkd.2015.03.028
K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Suppl 3):S1-S153.
van der Sande FM, Dekker MJ, Leunissen KML, Kooman JP. Novel Insights into the Pathogenesis and Prevention of Intradialytic Hypotension. Blood Purif. 2018;45(1-3):230-235. doi:10.1159/000485160
Kyriazis J, Kalogeropoulou K, Bilirakis L, et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004;66(3):1221-1231. doi:10.1111/j.1523-1755.2004.00875.x
Pakfetrat M, Roozbeh Shahroodi J, Malekmakan L, Zare N, Hashemi Nasab M, Hossein Nikoo M. Is there an association between intradialytic hypotension and serum magnesium changes?. Hemodial Int. 2010;14(4):492-497. doi:10.1111/j.1542-4758.2010.00477.x
Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int. 2006;10 Suppl 2:S16-S23. doi:10.1111/j.1542-4758.2006.00120.x
Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med. 1995;122(4):286-295. doi:10.7326/0003-4819-122-4-199502150-00009
Ong AC, Myint PK, Potter JF. Pharmacological treatment of postprandial reductions in blood pressure: a systematic review. J Am Geriatr Soc. 2014;62(4):649-661. doi:10.1111/jgs.12728
Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis. 2001;38(4 Suppl 4):S11-S17. doi:10.1053/ajkd.2001.28090
Sherman RA, Torres F, Cody RP. Postprandial blood pressure changes during hemodialysis. Am J Kidney Dis. 1988;12(1):37-39. doi:10.1016/s0272-6386(88)80069-6
Van Buren PN, Kim C, Toto R, Inrig JK. Intradialytic hypertension and the association with interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol. 2011;6(7):1684-1691. doi:10.2215/CJN.11041210
Takeda A, Toda T, Fujii T, Sasaki S, Matsui N. Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients?. Nephron Clin Pract. 2006;103(4):c137-c143. doi:10.1159/000092910
London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche JL. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade. Circulation. 1994;90(6):2786-2796. doi:10.1161/01.cir.90.6.2786
Ichihara A, Hayashi M, Kaneshiro Y, et al. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis. 2005;45(5):866-874. doi:10.1053/j.ajkd.2005.02.022
Abbott KC, Trespalacios FC, Agodoa LY, Taylor AJ, Bakris GL. beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality. Arch Intern Med. 2004;164(22):2465-2471. doi:10.1001/archinte.164.22.2465
Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto R. Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol. 2012;7(8):1300-1309. doi:10.2215/CJN.10010911
Agarwal R, Sinha AD, Pappas MK, Abraham TN, Tegegne GG. Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial. Nephrol Dial Transplant. 2014;29(3):672-681. doi:10.1093/ndt/gft515
Reeves PB, Mc Causland FR. Mechanisms, Clinical Implications, and Treatment of Intradialytic Hypotension. Clin J Am Soc Nephrol. 2018;13(8):1297-1303. doi:10.2215/CJN.12141017
Rocha A, Sousa C, Teles P, Coelho A, Xavier E. Frequency of intradialytic hypotensive episodes: old problem, new insights. J Am Soc Hypertens. 2015;9(10):763-768. doi:10.1016/j.jash.2015.07.007
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Şayeste Akkan Eren, İbrahim Güney, Sevil Fişekçi Oktar, Kenan Koşar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0)
